The Department of Dermatology, The Second Affiliated Hospital of Dalian Medical University, No. 467 Zhongshan Road, Shahekou District, Dalian, Liaoning, 116000, China.
National Clinical Research Center for Skin and Immune Disease, Beijing, 100024, China.
Arch Dermatol Res. 2024 Nov 30;317(1):57. doi: 10.1007/s00403-024-03546-4.
Identifying the characteristics of atopic dermatitis (AD) patients with its comorbidity has become increasingly crucial. We aimed to investigate the relevant factors associated with comorbidities in adults with AD. We analyzed cross-sectional data through univariate and multivariate regression analyses, encompassing 439 adult cases of AD from the Clinical Research and Homogenization Diagnosis and Treatment Project for Type 2 Inflammatory Dermatosis. It was found that 231 patients developed at least one comorbidity. 161 cases had a positive family history of atopy, 292 exhibited elevated IgE levels. A family history of allergic rhinitis or sinusitis was found to be associated with concurrent diseases (OR (95% CI): 2.92 (1.41-6.06) in model 1; 2.71 (1.27-5.77) in model 2; 3.59 (1.75-7.37) in model 3; 3.38 (1.62-7.05) in model 4; 3.60 (1.83-7.08) in model 5; 3.56 (1.78-7.12) in model 6). The linkage between elevated IgE levels and concurrent diseases with different classifications was negative (OR (95% CI): 0.51 (0.33-0.79) in model 1; 0.51 (0.33-0.80) in model 2; 0.51 (0.33-0.79) in model 3; 0.52 (0.33-0.81) in model 4; 0.45 (0.29-0.71) in model 5; 0.47 (0.30-0.73) in model 6). Scores for familial atopy (OR (95% CI): 1.56 (1.00-2.44) in model 2; 1.59 (1.03-2.48) in model 4; 1.84 (1.19-2.84) in model 6) were positively associated with comorbidities. Factors associated with comorbidity development in AD included a family history of allergic rhinitis or sinusitis, elevated IgE levels and scores indicating familial atopy. These relevant factors might contribute to improved discrimination and early intervention for comorbidities in individuals with AD.
识别特应性皮炎(AD)患者的合并症特征变得越来越重要。我们旨在研究与成人 AD 合并症相关的相关因素。我们通过单变量和多变量回归分析分析了横断面数据,其中包括来自 2 型炎症性皮肤病临床研究和同质化诊断与治疗项目的 439 例成人 AD 病例。结果发现,有 231 例患者至少出现一种合并症。161 例有特应性家族史,292 例 IgE 水平升高。家族性过敏性鼻炎或鼻窦炎病史与合并症相关(模型 1中的 OR(95%CI):2.92(1.41-6.06);模型 2 中的 OR(95%CI):2.71(1.27-5.77);模型 3 中的 OR(95%CI):3.59(1.75-7.37);模型 4 中的 OR(95%CI):3.38(1.62-7.05);模型 5 中的 OR(95%CI):3.60(1.83-7.08);模型 6 中的 OR(95%CI):3.56(1.78-7.12))。不同分类的 IgE 水平升高与合并症之间的联系呈负相关(模型 1 中的 OR(95%CI):0.51(0.33-0.79);模型 2 中的 OR(95%CI):0.51(0.33-0.80);模型 3 中的 OR(95%CI):0.51(0.33-0.79);模型 4 中的 OR(95%CI):0.52(0.33-0.81);模型 5 中的 OR(95%CI):0.45(0.29-0.71);模型 6 中的 OR(95%CI):0.47(0.30-0.73))。家族性特应性评分(模型 2 中的 OR(95%CI):1.56(1.00-2.44);模型 4 中的 OR(95%CI):1.59(1.03-2.48);模型 6 中的 OR(95%CI):1.84(1.19-2.84))与合并症呈正相关。AD 合并症发展的相关因素包括过敏性鼻炎或鼻窦炎家族史、IgE 水平升高和家族性特应性评分。这些相关因素可能有助于提高 AD 患者合并症的鉴别和早期干预。